openPR Logo
Press release

United States Pellagra Treatment Market Set for Growth as Advances in Nutritional Therapies and Awareness Drive Demand 2025 | Top key players - DSM, Merck KGaA, Foodchem International Corporation.

09-15-2025 07:58 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Pellagra Treatment Market

Pellagra Treatment Market

Market Overview:

The Pellagra Treatment Market is estimated to reach at a Significant CAGR during the forecast period (2024-2031).

The Pellagra Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Pellagra Treatment market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/pellagra-treatment-market?sz

The Pellagra Treatment Market refers to the healthcare segment focused on therapies, drugs, and nutritional supplements used to treat pellagra, a niacin (vitamin B3) deficiency disorder. It includes pharmaceutical interventions, fortified foods, and clinical management approaches aimed at addressing symptoms such as dermatitis, diarrhea, and dementia, while preventing disease recurrence and improving patient health outcomes.

Recent Key Developments of United States (U.S):

Continued Market Growth: The overall pellagra market is projected to see steady growth. A market report from June 1, 2025, estimated the 2025 market size at approximately $150 million, with a projected growth driven by increased awareness and improvements in treatment modalities.

Focus on Secondary Pellagra: Given the rarity of primary pellagra in the USA, recent case studies and research, such as a paper published on August 6, 2025, highlight the ongoing challenge of secondary pellagra. This form of the disease is caused by underlying medical conditions like chronic alcoholism, malabsorption disorders, or certain medications.

Emphasis on Niacin and Multivitamin Therapy: Published research in June and July 2025, including a case study on a patient with chronic diarrhea, reinforced the standard of care for pellagra treatment. This involves the therapeutic administration of niacin or niacinamide, often in conjunction with a well-balanced, high-protein diet and other vitamin supplements.

Research into Underlying Causes: An academic publication from July 9, 2024, (with a recent mention in 2025) and other ongoing research continue to underscore the importance of diagnosing and treating the root cause of pellagra, particularly for patients with co-morbidities like alcoholism or genetic disorders. This research emphasizes that successful long-term management requires addressing the underlying condition, not just the niacin deficiency.

Key Players:

Western Drugs Ltd.
DSM
Merck KGaA
Foodchem International Corporation
Jubilant Life Sciences Limited
Lasons
Bazayan & Co
Resonance Specialties Limited
Veer-Chemie

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=pellagra-treatment-market

Market Segmentation:

By Drug: Niacin, Niacinamide.

By Type: Primary Pellagra, Secondary Pellagra.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pellagra-treatment-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Pellagra Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Pellagra Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Pellagra Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Pellagra Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Pellagra Treatment Market in 2025?
◆ What is the projected growth rate of the Pellagra Treatment Market through 2033?
◆ Who are the key players in the Pellagra Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Pellagra Treatment Market Set for Growth as Advances in Nutritional Therapies and Awareness Drive Demand 2025 | Top key players - DSM, Merck KGaA, Foodchem International Corporation. here

News-ID: 4182059 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for Pellagra

Pellagra Treatment Market Opportunities and Trends With Leading Key Profiles Til …
The Pellagra Treatment Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/pellagra-treatment-market What is the projected
Pellagra Treatment Market Statistical Forecast, Trade Analysis 2024 -DSM, Merck …
DataM Intelligence has published a new research report on "Pellagra Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample Research PDF -
Idiopathic Pulmonary Fibrosis (IPF) Market Size, Share, Industry, Forecast and o …
Idiopathic Pulmonary Fibrosis (IPF) Market Global Idiopathic Pulmonary Fibrosis (IPF) Market Set for Remarkable Growth, Projected to Reach US$ 4,614.3 Million by 2030 The global Idiopathic Pulmonary Fibrosis (IPF) market, valued at US$ 2,184.4 million in 2022, is poised for substantial expansion, with projections reaching up to US$ 4,614.3 million by 2030. Anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period from 2024 to 2031, the
Respiratory Syncytial Virus (RSV) Market Size, Share, Industry, Forecast and out …
Respiratory Syncytial Virus (RSV) Market Global Respiratory Syncytial Virus (RSV) Market Set to Double in Size, Reaching USD 2.4 Billion by 2030 The global Respiratory Syncytial Virus (RSV) market, which achieved a notable USD 1.2 billion valuation in 2022, is poised for substantial growth, projected to reach USD 2.4 billion by 2030. A comprehensive market analysis indicates a robust Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period spanning 2024
Colorectal Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024 …
Colorectal Cancer Drugs Market Global Colorectal Cancer Drugs Market Set to Surge, Projected to Reach US$ 18.1 Billion by 2030 The Global Colorectal Cancer Drugs Market exhibited robust growth, reaching a valuation of US$ 13.6 billion in 2022, with expectations to soar to US$ 18.1 billion by 2030. Projections indicate a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period from 2023 to 2030. This surge is attributed to
Europe Electronic Medical Records (EMR) Market Growth by Applications, Sales, Gr …
Europe Electronic Medical Records (EMR) Market is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. This analysis provides an examination of various market segments that are relied upon to observe the fastest development amid the estimated forecast frame. The report encompasses market definition, currency and pricing, market segmentation, market overview, premium insights, key insights and company profile of the